US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,433.82

-9.9231-0.69%

Number of Gainers:12

Number of Losers:8

Number of Flat:- -

PE:- -

High:1,448.24

Open:1,447.71

Low:1,424.24

Close:1,443.75

Loading ...

APT Price Jumps as Bitwise Files for an Aptos ETF in Delaware

APT Medical Gets Medical Device Registration for Medical Catheter Sensor

MT Newswires Live

Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract -- Barrons.com

U.S. health officials evaluating Moderna bird flu vaccine, Bloomberg reports

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

BRIEF-Trump Team Weighs Pulling Funding For Moderna Bird Flu Vaccine-Bloomberg News

Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine-Bloomberg News

THOMSON REUTERS

Medibank Announces $160 Million Customer Give Back Amid COVID-19 Support

Vir Biotechnology reports Q4 EPS (76c), consensus (87c)

BRIEF-Vir Biotechnology Q4 Cash & Investments USD 1,100 Million

Vir Biotechnology Inc: Qtrly Shr Loss $0.76

THOMSON REUTERS

Vir Biotechnology Inc: Expects Its Cash, Cash Equivalents and Investments to Fund Its Operations Into Mid-2027.

THOMSON REUTERS

Vir Biotechnology Q4 Cash & Investments USD 1,100 Million

THOMSON REUTERS

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Is Johnson & Johnson (JNJ) the Cheap Global Stock to Buy Right Now?

Haleon PLC Announces Shareholder Structure Change with Pfizer’s Conversion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1433.8289,"timestamp":1741798301400,"preClose":1443.752,"halted":0,"volume":42917472,"delay":0,"changeRate":-0.006873,"change":-9.923096,"pbRate":4.031245,"amount":2406679289.031307,"amplitude":0.016623,"prevYearClose":1274.8187,"fiveDayClose":1470.1858,"twentyDayClose":1369.0735,"turnoverRate":0.002775,"marketCap":1181251223193,"floatMarketCap":1161156274786,"peRate":32.193039},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1448.2382,"amplitude":0.016623,"preClose":1443.752,"low":1424.2384,"pbRate":"4.031245","latestPrice":1433.8153,"volume":42912375,"delay":0,"open":1447.7053,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1470.1858,"twentyDayClose":1369.0735,"sixtyDayClose":1282.6448,"secType":"PLATE","market":"US","turnoverRate":0.002775,"peRate":32.193039,"marketCap":1181240180377,"floatMarketCap":1161145215586,"timestamp":1741798298118,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":12,"down":8,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514829633","title":"APT Price Jumps as Bitwise Files for an Aptos ETF in Delaware","url":"https://stock-news.laohu8.com/highlight/detail?id=2514829633","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514829633?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:40","pubTimestamp":1740638434,"startTime":"0","endTime":"0","summary":"Bitwise files for Aptos ETF trust in Delaware, marking the first move toward a US-based exchange-traded fund for APT.SEC approval process awaits, requiring a formal application, review, and potential modifications before a launch can happen.APT surges 12.4% on news, signaling strong market interest as institutional investors eye altcoin ETFs beyond Bitcoin and Ethereum.Bitwise Asset Management has taken the first step toward launching an Aptos  exchange-traded fund , filing for a Delaware trust linked to the proposed product.This move positions Bitwise as the first asset manager to pursue an ETF dedicated to Aptos.Next, Bitwise will need to submit a formal application to the US Securities and Exchange Commission . This will include a detailed prospectus outlining the ETF’s structure, investment strategy, and how it plans to track Aptos.The SEC will then review the application, which could take several months. It can either approve, reject, or request modifications to the proposal.The c","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/04/bic_Aptos_APT_1-covers_neutral-850x478.jpg.webp","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/04/bic_Aptos_APT_1-covers_neutral-850x478.jpg.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/bitwise-aptos-etf-filing/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4550","BK4588","APT.USD.CC","BK4086","FDN","SOL","BK4519","BTC.USD.HKCC","APT","BK4129","ETH.USD.HKCC","APT.USD.HKCC","BK4568","BTC","BK4601","BK4585","SOL.USD.HKCC","ETH","BTC.USD.CC","ETH.USD.CC"],"gpt_icon":0},{"id":"2514584267","title":"APT Medical Gets Medical Device Registration for Medical Catheter Sensor","url":"https://stock-news.laohu8.com/highlight/detail?id=2514584267","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514584267?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:29","pubTimestamp":1740637755,"startTime":"0","endTime":"0","summary":"APT Medical  subsidiary Hunan Apt Medical Device obtained a medical device registration certificate for its disposable magnetic positioning pressure monitoring radiofrequency ablation catheter.The device provides information on the location of the catheter in the heart, according to a Thursday filing with the Shanghai bourse.Shares of the company were down 1% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0251","APT.USD.CC","BK4086","BK4568","APT.USD.HKCC","APT","688617"],"gpt_icon":0},{"id":"2514894190","title":"Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2514894190","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514894190?lang=en_us&edition=fundamental","pubTime":"2025-02-27 07:23","pubTimestamp":1740612180,"startTime":"0","endTime":"0","summary":"Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services Department was reevaluating its $590 million contract to develop a bird flu vaccine.Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.Bloomberg News reported that HHS was evaluating the contract, awarded in the final days of the Biden administration, as part of a push to examine spending on messenger RNA-based vaccines.The U.S. is in the middle of a widening outbreak of bird flu that has spread through dairy herds and poultry flocks, infected dozens of people, and helped contribute to soaring egg prices at the grocery store.Representatives from Health and Human Services, the White House, and Moderna weren't immediately available for comment.Shares were down 5.8% in after-hours trading. Moderna stock is down 19% this year.Moderna received the contract during Biden's last week in the White House, as it was r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4139","BK4501","HHS","BK4534","BK4009","BK4551","BK4568","BK4548","BK4588","BK4532","BK4585","BK4533"],"gpt_icon":1},{"id":"2514916678","title":"U.S. health officials evaluating Moderna bird flu vaccine, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2514916678","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514916678?lang=en_us&edition=fundamental","pubTime":"2025-02-27 07:00","pubTimestamp":1740610823,"startTime":"0","endTime":"0","summary":"U.S. health officials are reviewing the $590M deal for bird flu shots that the Biden administration awarded to Moderna (MRNA) in January, writes Ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/u-s-health-officials-evaluating-moderna-bird-flu-vaccine-bloomberg-reports?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/u-s-health-officials-evaluating-moderna-bird-flu-vaccine-bloomberg-reports?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4533","BK4139","MRNA","BK4551","BK4585","BK4532","BK4534","BK4501","BK4588","BK4548"],"gpt_icon":0},{"id":"2514389918","title":"Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389918","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389918?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:45","pubTimestamp":1740609939,"startTime":"0","endTime":"0","summary":"Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports Feb 26  - U.S. health officials are reevaluating a $590 million contract for bird flu shots that was awarded to Moderna MRNA.O, Bloomberg News reported on Wednesday, citing people familiar with the matter.The U.S. government had awarded Moderna $590 million in January to advance the development of its bird flu vaccine.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL3N3PH24H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4551","BK4533","BK4588","BK4548","BK4585","BK4501","BK4532","BK4534","MRNA","BK4568"],"gpt_icon":1},{"id":"2514899556","title":"BRIEF-Trump Team Weighs Pulling Funding For Moderna Bird Flu Vaccine-Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2514899556","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514899556?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:42","pubTimestamp":1740609741,"startTime":"0","endTime":"0","summary":"BRIEF-Trump Team Weighs Pulling Funding For Moderna Bird Flu Vaccine-Bloomberg NewsFeb 26 (Reuters) - TRUMP TEAM WEIGHS PULLING FUNDING FOR MODERNA BIRD FLU VACCINE-BLOOMBERG NEWSSource text: https://tinyurl.com/yc3bwksx ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4139","BK4548","BK4532","BK4568","BK4551","BK4585","BK4588","MRNA","BK4533","BK4534"],"gpt_icon":0},{"id":"2514995388","title":"Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine-Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2514995388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514995388?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:41","pubTimestamp":1740609694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4501","BK4588","BK4551","BK4532","BK4585","MRNA","BK4568","BK4139","BK4534","BK4533","BK4548"],"gpt_icon":0},{"id":"2514089611","title":"Medibank Announces $160 Million Customer Give Back Amid COVID-19 Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2514089611","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514089611?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:08","pubTimestamp":1740607721,"startTime":"0","endTime":"0","summary":"An announcement from Medibank Private Ltd. ( ($AU:MPL) ) is now available. Medibank Private Ltd. has announced a $160 million return to its custome...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medibank-announces-160-million-customer-give-back-amid-covid-19-support?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medibank-announces-160-million-customer-give-back-amid-covid-19-support?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4535","BNTX","BK4568","BK4585","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2514898197","title":"Vir Biotechnology reports Q4 EPS (76c), consensus (87c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898197","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898197?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:20","pubTimestamp":1740604853,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $12.4M, consensus $8.1M. “2024 was a year of transformation for Vir Biotechnology (VIR) as we successfully defined and executed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-reports-q4-eps-76c-consensus-87c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-reports-q4-eps-76c-consensus-87c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VIR","BK4568","BK4585","BK4535"],"gpt_icon":0},{"id":"2514843860","title":"BRIEF-Vir Biotechnology Q4 Cash & Investments USD 1,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514843860","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514843860?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603946,"startTime":"0","endTime":"0","summary":"BRIEF-Vir Biotechnology Q4 Cash & Investments USD 1,100 Million\n\n\nFeb 26 (Reuters) - Vir Biotechnology Q4 revenue USD 12.4 million vs. IBES estimate USD 8.14 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXB1EDAB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4139","VIR","BK4568"],"gpt_icon":0},{"id":"2514898479","title":"Vir Biotechnology Inc: Qtrly Shr Loss $0.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898479?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXB1EDAB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4535","VIR","BK4585","BK4139"],"gpt_icon":0},{"id":"2514898474","title":"Vir Biotechnology Inc: Expects Its Cash, Cash Equivalents and Investments to Fund Its Operations Into Mid-2027.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898474?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXB1EDAB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","BK4535","VIR","BK4585"],"gpt_icon":0},{"id":"2514860852","title":"Vir Biotechnology Q4 Cash & Investments USD 1,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514860852","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514860852?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXB1EDAB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","VIR","BK4139","BK4535","BK4568"],"gpt_icon":0},{"id":"2514898604","title":"Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898604","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898604?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025. - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA Breakthrough and Fast Track designations and EMA PRIME and Orphan Drug designations. SAN FRANCISCO, February 26, 2025----Vir Biotechnology, Inc. , today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2024.\"2024 was a year of transformation for Vir Biotechnology as we successfully defined and executed on our renewed strategic direction, focusing our resources on our most promising programs in infectious diseases and oncology,\" said Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. \"As we enter 2025, we are poised for significant advancement with the initiation of our Phase 3 registrational program in chronic hepatitis delta and further clinical progression of our dual-masked T-cell engagers in sol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vir-biotechnology-provides-corporate-reports-210500295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FPI","BK4121","BK4585","IE00BYQQ9H92.USD","BK4006","CHB","LU1093756168.USD","BK4533","BK4567","LU1093756325.SGD","IE00B19Z4B17.USD","LU0266512127.USD","IE00B66KJ199.SGD","BK4234","LU2413666699.HKD","BK4504","LU2413666426.HKD","LU1721428933.USD","LU0347712357.USD","BK4084","BK4018","LU0456854461.SGD","LU2065731478.USD","BK4568","CHD","BK4213","IE00B7SZL793.SGD","MTD","BK4548","CRC","BK4139","LU1585245621.USD","IE0031619046.USD","CRS","VIR","IE00BFXG0V08.USD","BK4588","LU1430594728.SGD","BK4535"],"gpt_icon":0},{"id":"2514186229","title":"Is Johnson & Johnson (JNJ) the Cheap Global Stock to Buy Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186229","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514186229?lang=en_us&edition=fundamental","pubTime":"2025-02-27 04:37","pubTimestamp":1740602254,"startTime":"0","endTime":"0","summary":"We recently published a list of 7 Cheap Global Stocks to Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson  stands against other cheap global stocks to buy right now.As geographic markets became more disconnected, the stock markets in the USA, Europe, and APAC had quite different performances, with the former leading by a wide margin in 2023-2024. For reference, the 5-year performance of the German stock market lagged that of the US by 57%, China lagged the US by 94%, and Japan lagged the US by 58%. In light of the proliferating geopolitical challenges, which still persist as the new Trump 2.0 admini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-cheap-global-203734968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1718418525.SGD","LU0203345920.USD","LU1162221912.USD","BK4550","IE00B7SZLL34.SGD","IE00BDGV0183.EUR","LU1267930813.SGD","LU1674673428.USD","LU0795875086.SGD","LU0114720955.EUR","LU1032466523.USD","LU1732799900.SGD","IE0034235303.USD","LU1221951129.SGD","BK4534","LU0795875169.SGD","LU1894683264.USD","BK4592","IE0009355771.USD","LU1066051225.USD","LU1894683348.USD","LU1066053197.SGD","IE00B42XCP33.USD","LU0466842654.USD","LU1066051811.HKD","LU1061106388.HKD","BK4007","LU0882574055.USD","LU1221951046.USD","LU2505996681.GBP","SG9999002232.USD","BK4585","LU1585245621.USD","BK4559","BK4568","LU1674673691.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1732800096.USD","LU1778281490.HKD","JNJ","LU2592432038.USD","LU0889566641.SGD","BK4533","LU2430703095.HKD","LU2430703178.SGD","LU2468319806.SGD","LU2133065610.SGD","LU0640476718.USD"],"gpt_icon":0},{"id":"2514864837","title":"Haleon PLC Announces Shareholder Structure Change with Pfizer’s Conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2514864837","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514864837?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:47","pubTimestamp":1740595644,"startTime":"0","endTime":"0","summary":"Haleon PLC Sponsored ADR ( ($HLN) ) has issued an announcement. On February 26, 2025, Haleon PLC announced a significant change in its shareholder ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/haleon-plc-announces-shareholder-structure-change-with-pfizers-conversion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/haleon-plc-announces-shareholder-structure-change-with-pfizers-conversion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU0321505439.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU0321505868.SGD","HLN","LU0289739699.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","LU1057294990.SGD","IE00BLSP4239.USD","LU0306806265.USD","SGXZ57979304.SGD","BK4534","LU0058720904.USD","LU0868494617.USD","BK4533","LU1023059063.AUD","IE0002270589.USD","SG9999003800.SGD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","BK4588","BK4183","LU1066051498.USD","LU1894683264.USD","SG9999011175.SGD","IE00BBT3K403.USD","BK4599","SG9999002224.SGD","PFE","SG9999013999.USD","SG9999002232.USD","LU0306807586.USD","LU1066053197.SGD","BK4585","BK4550","IE00B19Z3B42.SGD","LU1894683348.USD","BK4568","LU0225284248.USD","BK4007","LU1883839398.USD","BK4581","LU0122379950.USD","LU0225771236.USD","BK4592"],"gpt_icon":0}],"pageSize":16,"totalPage":21,"pageCount":20,"totalSize":329}]}}